Nearly 300 jobs have been saved after Amgen agreed a deal with Pfizer to buy its Irish manufacturing plant in Dun Laoghaire, Co Dublin.
Approximately 240 employees at the site will transfer their employment to Amgen with the remaining 40 staff continuing to be employed by Pfizer.
Madhu Balachandran, Head of Manufacturing, Amgen, said the company was impressed with the “technical expertise and commitment to excellence” workers demonstrated at the plant.
Amgen says it intends to develop the capability to formulate and fill its biological products at the site.
The 37,000 square-metre facility has freeze dry product and liquid vial-filling operations. Under the terms of the deal, Amgen will manufacture products by Pfizer for an interim period. Pfizer will also lease a section of the plant for a short period.
The plant is one of three manufacturing facilities Pfizer is looking to sell in the country.